Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Baxter
Merck
Moodys
AstraZeneca

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Bayer Pharms Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for BAYER PHARMS, and what generic and branded alternatives to BAYER PHARMS drugs are available?

BAYER PHARMS has thirty-one approved drugs.



Summary for Bayer Pharms
US Patents:0
Tradenames:24
Ingredients:23
NDAs:31

Drugs and US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms MEZLIN mezlocillin sodium monohydrate INJECTABLE;INJECTION 050549-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Bayer Pharms AZLIN azlocillin sodium INJECTABLE;INJECTION 062417-003 Oct 12, 1982 DISCN No No   Start Trial   Start Trial
Bayer Pharms VI-DOM-A vitamin a palmitate CAPSULE;ORAL 080972-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Bayer Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms NIMOTOP nimodipine CAPSULE;ORAL 018869-001 Dec 28, 1988 4,406,906   Start Trial
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 3,660,577   Start Trial
Bayer Pharms MYCELEX-G clotrimazole TABLET;VAGINAL 019069-001 Apr 19, 1985 3,839,573   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Merck
Mallinckrodt
AstraZeneca
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.